Concepedia

Małgorzata Bobrowicz

MB

Statistics

Publications

13

Citations

357

H-Index

12

Active since

2014

Affiliations

Medical University of Warsaw(Current)

University Hospital of Zurich

Postgraduate School of Molecular Medicine

University of Zurich

University of Lausanne

Małgorzata Bobrowicz is an author at Medical University of Warsaw specializing in oncology, cancer immunology, and immunology.

ORCID

Publications per year

2014–2025

13

Publications

13

Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation

Ieva Saulīte, Desislava Ignatova, Yun‐Tsan Chang et al. · OncoImmunology · 2020 · 62 citations · Full text

, , +17

HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies

Małgorzata Bobrowicz, Michal Dwojak, Beata Pyrzyńska et al. · Blood · 2017 · 52 citations · Full text

, , +13

Inhibition of thioredoxin-dependent H2O2 removal sensitizes malignant B-cells to pharmacological ascorbate

Agnieszka Graczyk‐Jarzynka, Agnieszka Góral, Angelika Muchowicz et al. · Redox Biology · 2018 · 42 citations · Full text

, , +17

FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy

Beata Pyrzyńska, Michal Dwojak, Abdessamad Zerrouqi et al. · OncoImmunology · 2018 · 34 citations · Full text

, , +15

Divergent LAG-3 versus BTLA, TIGIT, and FCRL3 expression in Sézary syndrome

Florian Anzengruber, Desislava Ignatova, Tanja Schlaepfer et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2019 · 29 citations · Full text

, , +17

1–5 of 13